⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 2, 2024Pain ManagementOpen Access

Economic burden and dosing trends of buprenorphine buccal film and transdermal patch in chronic low back pain

Vladimir Zah Filip Stanicic Djurdja Vukicevic Dimitrije Grbic

View Full Paper

Ask AI

Bookmark

Share

Abstract

Exploring prescribing trends and economic burden of chronic low back pain (cLBP) patients prescribed buprenorphine buccal film (Belbuca®) or transdermal patches.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Zah et al. (2024) studied this question.

synapsesocial.com/papers/68e70c44b6db643587685891 https://doi.org/10.1080/17581869.2024.2348989

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Treatment Characteristics of Chronic Low Back Pain Patients Treated with Buprenorphine Buccal Film or Transdermal PatchRetrospective Study · 2024 · 6 citations
2Healthcare Costs and Resource Use Among Chronic Low‐Back Pain Patients Treated With Belbuca or Buprenorphine Transdermal Patches: A Retrospective US Medicare Claims Analysis2025
3Serious treatment-emergent adverse events in chronic low back pain patients treated with buprenorphine or oral opioids: a retrospective commercial claims analysis2024 · 1 citations
4Economic and Treatment Burden of Chronic Low-Back Pain Patients Transitioning from Short-Acting to Long-Acting Opioids or Buprenorphine Buccal Film: US Claims AnalysisOriginal Research · 2026
5Evaluation of the Efficacy of Transdermal Buprenorphine in Chronic Low Back Pain: A Meta‐Analysis of Randomized Clinical TrialsRandomized Controlled Trial · 2026